Rebus Holdings Inc (RBSH)

[Mrragu]

The possible wild card that everyone overlooks is RIDGEWAY THERAPEUTICS. In sept 2018 NSPX and Ridgeway entered in to a licensing agreement For IP related to Adenosine drug platforms. Ridgeway is a private co. so there is no public information on where this agreement is headed but just the fact that another company is investigating and possibly re purposing the drug to treat covid-19 is reason to hold on. Colin Hislop Ridgeway CEO has vast experience in new drug applications and affiliations with several drug companies including Gildead!